Implication for health policy/practice/research/medical education:
Sodium-glucose cotransporter-2 inhibitors can provide a new strategy to prevent progression of chronic renal failure in individuals with IgA-nephropathy.
Please cite this paper as: Ragati Haghi Y, Dieti A, Forootan M. Administration of sodium-glucose cotransporter-2 inhibitors in IgA nephropathy; a new strategy in the management? J Nephropathol. 2023;12(2):e21429. DOI: 10.34172/jnp.2023.21429.